Loading...

PerCP/Cyanine5.5 anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M1slash70_PerCPCyanine55_CD11b_Antibody_111918
C57BL/6 splenocytes were blocked with TruStain FcX™ (anti-mouse CD16/32) Antibody then stained with Ly-6G/Ly-6C (Gr-1) APC and CD11b (clone M1/70) PerCP/Cyanine5.5 (left) or rat IgG2b, κ PerCP/Cyanine5.5 isotype control (right).
  • M1slash70_PerCPCyanine55_CD11b_Antibody_111918
    C57BL/6 splenocytes were blocked with TruStain FcX™ (anti-mouse CD16/32) Antibody then stained with Ly-6G/Ly-6C (Gr-1) APC and CD11b (clone M1/70) PerCP/Cyanine5.5 (left) or rat IgG2b, κ PerCP/Cyanine5.5 isotype control (right).
Compare all formats See PerCP/Cyanine5.5 spectral data
Cat # Size Price Quantity Check Availability Save
101227 25 µg £62
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101228 100 µg £200
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PerCP/Cyanine5.5 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD11b antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  2. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  3. Zhou R, et al. 2022. EBioMedicine. 75:103762. PubMed
  4. Grandjean CL, et al. 2021. Sci Adv. 7:. PubMed
  5. Leslie J, et al. 2021. Sci Rep. 11:1415. PubMed
  6. Zheng J, et al. 2022. Front Pharmacol. 13:866228. PubMed
  7. Zhu Y, et al. 2022. Nat Commun. 13:4282. PubMed
  8. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  9. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  10. Guo H, Cooper S, Friedman A, et al. 2017. PLoS One. 10.1371/journal.pone.0150809. PubMed
  11. Orberg E, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.53. PubMed
  12. Lang J, et al. 2020. Nat Commun. 11:1338. PubMed
  13. Gordan S, et al. 2020. Cell Reports. 29(10):3033-3046.e4.. PubMed
  14. Milasan A, et al. 2017. J Am Heart Assoc. 10.1161/JAHA.117.006892. PubMed
  15. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  16. Tian WJ, et al. 2021. Clin Exp Pharmacol Physiol. 48:902. PubMed
  17. Ferrao Blanco MN, et al. 2022. Br J Pharmacol. 179:2771. PubMed
  18. Osokine I, et al. 2022. Cell Rep. 38:110329. PubMed
  19. Agarwalla P, et al. 2022. Nat Biotechnol. 40:1250. PubMed
  20. Chae CS, et al. 2022. Cancer Discov. 12:1904. PubMed
  21. Yang K, et al. 2022. Sci Immunol. 7:eabn2888. PubMed
  22. Marquardt RM, et al. 2022. Int J Mol Sci. 23: . PubMed
  23. Halin C, et al. 2022. EMBO J. 41:e111528. PubMed
  24. Auguste YSS, et al. 2022. Nat Neurosci. 25:1273. PubMed
  25. Schepers M, et al. 2023. Brain Behav Immun. 109:1. PubMed
  26. García-García A, et al. 2023. Bioact Mater. 24:174. PubMed
  27. Glaubitz J, et al. 2023. Gut. :. PubMed
  28. Zhang K, et al. 2023. Nat Metab. 5:129. PubMed
  29. Arimoto KI, et al. 2023. Nat Commun. 14:251. PubMed
  30. Zhang B, et al. 2023. Signal Transduct Target Ther. 8:28. PubMed
  31. Lazure F, et al. 2023. Nat Commun. 14:535. PubMed
  32. Murakata Y, et al. 2023. Front Cardiovasc Med. 9:1075358. PubMed
  33. Meng S, et al. 2023. Stem Cell Investig. 10:2. PubMed
  34. Drummer C, et al. 2023. Front Immunol. 14:1113883. PubMed
  35. Peng W, et al. 2022. Cell Mol Life Sci. 79:602. PubMed
  36. Chen H, et al. 2023. Nat Commun. 14:941. PubMed
  37. Zhu S, et al. 2023. J Nanobiotechnology. 21:81. PubMed
  38. Guo D, et al. 2023. Cell Biosci. 13:51. PubMed
  39. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  40. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
  41. Shen Z, et al. 2023. iScience. 26:106572. PubMed
  42. Haensel D, et al. 2023. Nat Commun. 14:2685. PubMed
  43. Wilden A, et al. 2022. Front Immunol. 13:991295. PubMed
  44. Ortiz G, et al. 2020. Front Immunol. 11:1713. PubMed
  45. McNamara HA, et al. 2020. Cell Host Microbe. 572:28. PubMed
  46. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  47. Gern BH, et al. 2021. Cell Host Microbe. 29(4):594-606.e6. PubMed
  48. Kaczanowska S, et al. 2021. Cell. 184(8):2033-2052.e21. PubMed
  49. Huang X, et al. 2021. Stem Cells Int. 2021:8138374. PubMed
  50. Hong M, et al. 2021. Int J Mol Sci. 22:. PubMed
  51. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  52. Zhao X, et al. 2022. Front Mol Biosci. 9:786864. PubMed
  53. Meng W, et al. 2021. JCI Insight. 6:. PubMed
  54. John S, et al. 2020. Sci Rep. 10:11377. PubMed
  55. Hastings AK, et al. 2019. iScience. 13:339. PubMed
  56. Kim SS, et al. 2022. Cancers (Basel). 14:. PubMed
  57. Hofmann I, et al. 2022. J Pharmacol Exp Ther. Online ahead of print. PubMed
  58. Leach SM, et al. 2020. Cell Rep. 33:108337. PubMed
  59. Dong L, et al. 2021. Cancer Cell. . PubMed
  60. Shen Y, et al. 2021. Comput Struct Biotechnol J. 19:5360. PubMed
  61. Súarez-López L, et al. 2021. iScience. 24:103406. PubMed
  62. Zasłona Z, et al. 2014. J Immunol. 193:4245. PubMed
  63. Kobayashi T, et al. 2019. Cell. 176:982. PubMed
  64. Postat J et al. 2018. Immunity. 49(4):654-665 . PubMed
  65. Fu B et al. 2017. Immunity. 47(6):1100-1113 . PubMed
  66. Chen L, et al. 2019. Cell Mol Gastroenterol Hepatol. 7:623. PubMed
  67. Kenichi Shimada et al. 2018. Immunity. 49(5):873-885 . PubMed
  68. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  69. Biswas S, et al. 2021. Nature. 591:464. PubMed
  70. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  71. Yuan Q, et al. 2021. Cell Reports. 34(5):108724. PubMed
  72. Zheng H, et al. 2021. Frontiers in Cell and Developmental Biology. 9:641527. PubMed
  73. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  74. Castellanos CA, et al. 2021. Sci Immunol. 6:eabh0707. PubMed
  75. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  76. Amano C, et al. 2015. PLoS One. 10: 0137207. PubMed
  77. Sun P, et al. 2015. J Hepatol. . PubMed
  78. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  79. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  80. Zhu B, et al. 2021. Immunity. 54(6):1200-1218.e9. PubMed
  81. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  82. Nguyen SL, et al. 2021. Sci Rep. 11:4217. PubMed
  83. Cai B, et al. 2021. Mol Cancer. 20:165. PubMed
  84. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  85. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  86. Khandelwal P, et al. 2013. PLoS One. 8:64193. PubMed
  87. Neubert K, et al. 2014. J Immunol. 192:5830. PubMed
  88. Galle E, et al. 2022. Genome Biol. 23:207. PubMed
  89. Jiao H, et al. 2021. Cell. 184(11):2896-2910.e13. PubMed
  90. Lu S, et al. 2020. JCI Insight. 5:00. PubMed
  91. Anastasiou M, et al. 2021. JCI Insight. 6:. PubMed
  92. Koh EH, et al. 2018. Diabetes. 67(12). PubMed
  93. Nakamura‐Ishizu A et al. 2018. Cell reports. 25(7):1772-1785 . PubMed
  94. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  95. Jeong SJ, et al. 2021. Autophagy. 17:3740. PubMed
  96. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  97. Plein A, et al. 2018. Nature. 562:223. PubMed
  98. Park D, et al. 2020. Cancer Res. 80:4172. PubMed
  99. Raineri D, et al. 2021. Biomedicines. 10:. PubMed
  100. JI B, et al. 2016. Cell Death Differ. 23:759-75. PubMed
  101. Bunn P, et al. 2014. J Immunol. 192:3709. PubMed
  102. Nishi C, et al. 2014. Mol Cell Biol. 34:1512. PubMed
  103. Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed
  104. Gu H, et al. 2018. Aging (Albany NY). 1.525694444. PubMed
  105. Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed
  106. Xu G, et al. 2022. Cell Death Dis. 13:888. PubMed
  107. Hu J, et al. 2020. Theranostics. 7.154166667. PubMed
  108. Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
  109. Bogie JF, et al. 2020. Ther Adv Chronic Dis. 11:2040622320947378. PubMed
  110. Nayak RR, et al. 2021. Cell Host Microbe. 29(3):362-377.e11. PubMed
  111. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  112. Lu CY, et al. 2020. J Neurosci. 40:9602. PubMed
  113. Okamura T, et al. 2021. Front Immunol. 12:669629. PubMed
  114. Qian SJ, et al. 2021. Front Immunol. 12:711337. PubMed
  115. Wang J, et al. 2021. Nat Commun. 12:6198. PubMed
  116. Fennell LM, et al. 2020. EMBO J. 39:e103303. PubMed
  117. Guo P, et al. 2021. J Immunol. 207:408. PubMed
  118. Li W, et al. 2021. Front Pharmacol. 12:697483. PubMed
  119. Bretscher P, et al. 2015. EMBO Mol Med. 7:593. PubMed
  120. Pereira JA, et al. 2020. Hum Mol Genet. 29:1253. PubMed
  121. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  122. Yu Y, et al. 2022. Nat Commun. 13:6857. PubMed
  123. Xu Z, et al. 2020. Cancer Immunol Res. 1354:8. PubMed
  124. Zhu H, et al. 2021. Cell Metabolism. :. PubMed
  125. Harb H, et al. 2021. Immunity. 54(6):1186-1199.e7. PubMed
  126. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  127. Lu S, et al. 2020. Arterioscler Thromb Vasc Biol. 40:394. PubMed
  128. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  129. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  130. Xu M, et al. 2022. Genes Dis. 9:429. PubMed
  131. Sun L, et al. 2015. J Immunol. 194:4891. PubMed
  132. Mishra BB, et al. 2017. Nat Microbiol. 2:17072. PubMed
  133. Uribesalgo I, et al. 2019. EMBO Mol Med. 11:e9266. PubMed
  134. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  135. Sharma A, et al. 2020. Cell. 183(2):377-394.e21. PubMed
  136. Liu Z, et al. 2021. Immunity. 54(2):247-258.e7. PubMed
  137. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  138. Carbone C, et al. 2021. J Immunother Cancer. 9:. PubMed
  139. Dagher T, et al. 2021. J Exp Med. 218:. PubMed
  140. Anger-Góra N, et al. 2021. Oncol Lett. 22:582. PubMed
  141. Deczkowska A, et al. 2017. Nat Commun. 8:717. PubMed
  142. Chung L et al. 2018. Cell host & microbe. 23(2):203-214 . PubMed
  143. Sasaki T, et al. 2020. Cell Reports. 28(1):202-217.e7.. PubMed
  144. Zhao D, et al. 2020. Cancer Discov. 10:1374. PubMed
  145. Cruz-Herranz A, et al. 2021. JCI Insight. 6: . PubMed
  146. Covarrubias AJ, et al. 2020. Nat Metab. 1265:2. PubMed
  147. Stowe CL, et al. 2019. eLife. 0.333333333333333. PubMed
  148. Chatterjee D, et al. 2021. Cell Reports. 35(2):108996. PubMed
  149. Grauel AL, et al. 2020. Nat Commun. 4.84375. PubMed
  150. Wu S, et al. 2022. BMC Immunol. 23:17. PubMed
  151. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  152. Coronel MM, et al. 2020. Sci Adv. 6:eaba5573. PubMed
  153. Kyburz A, et al. 2019. J Allergy Clin Immunol. 143:1496. PubMed
  154. Lin W, et al. 2019. EBioMedicine. 49:133. PubMed
  155. Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed
  156. Brown SM et al. 2017. Endocrinology. 158(10):3592-3604 . PubMed
  157. López MJ, et al. 2018. Invest Ophthalmol Vis Sci. 59:5671. PubMed
  158. Sydney Lavoie et al. 2019. eLife. 8 pii: e39982. PubMed
  159. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  160. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  161. Chruewkamlow N, et al. 2021. Stem Cell Res Ther. 12:520. PubMed
  162. Vachon L, et al. 2022. Theranostics. 12:1440. PubMed
  163. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  164. Bravo-Caparrós I, et al. 2020. FASEB J. 34:5951. PubMed
  165. Ni C, et al. 2021. Infect Immun. 89:. PubMed
  166. Pandit M, et al. 2021. Eur J Immunol. 51:1461. PubMed
  167. Carestia A, et al. 2019. Cell Rep. 28:896. PubMed
  168. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  169. Wang Z et al. 2018. Immunity. 49(1):80-92 . PubMed
  170. Bhattacharya A, et al. 2018. Neuropsychopharmacology. 43:2586. PubMed
  171. Han Y, et al. 2022. Int J Biol Sci. 18:5653. PubMed
  172. Hsu M, et al. 2022. Nat Immunol. 23:581. PubMed
  173. Sakamoto K, et al. 2021. Immunity. 54:2321. PubMed
  174. Raoof R, et al. 2021. J Neurosci. 41:8249. PubMed
  175. Guo D, et al. 2022. Bone Res. 10:45. PubMed
  176. Tozuka M, et al. 2016. J Dermatol Sci. 82: 38-45. PubMed
  177. Sharif O, et al. 2013. J Immunol. 190:5640. PubMed
  178. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  179. Muri J, et al. 2020. eLife. 9:e53627.. PubMed
  180. Winchell CG, et al. 2020. Front Immunol. 1.077083333. PubMed
  181. Yu JM, et al. 2019. Nat Commun. 4.388888889. PubMed
  182. Hightower RM, et al. 2019. Mol Ther. 28:189. PubMed
  183. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  184. Bitschar K, et al. 2019. Nat Commun. 10:2730. PubMed
  185. Chen Z, et al. 2019. Mol Med Rep. 19:3210. PubMed
  186. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  187. Da Mesquita S, et al. 2021. Science Advances. 7(21):. PubMed
  188. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  189. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  190. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  191. Bennett FC, et al. 2018. Neuron. 98:1170. PubMed
  192. Yang X, et al. 2018. Sci Rep. 8:188. PubMed
  193. Draijer C, et al. 2018. Sci Rep. 8:5105. PubMed
  194. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  195. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  196. Gu H, et al. 2021. Elife. 10:. PubMed
  197. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  198. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  199. Dallari S, et al. 2021. Cell Host Microbe. 29(6):1014-1029.e8. PubMed
  200. Lazarian G, et al. 2021. Cancer Cell. 39(3):380-393.e8. PubMed
  201. Rustenhoven J, et al. 2021. Cell. 184(4):1000-1016.e27. PubMed
  202. Liao Y, et al. 2020. Theranostics. 7.113888889. PubMed
  203. Ding R, et al. 2022. J Neuroinflammation. 19:137. PubMed
  204. Xu JL, et al. 2022. Front Pharmacol. 13:911663. PubMed
  205. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  206. Hakim R, et al. 2021. J Neurosci. 41:8441. PubMed
  207. Chen M, et al. 2019. Cell Stem Cell. 25:501. PubMed
  208. Muri J, et al. 2020. Cell Reports. 29(9):2731-2744.e4.. PubMed
  209. Muchenditsi A, et al. 2017. Am J Physiol Gastrointest Liver Physiol. 313:G39. PubMed
  210. Tothova Z et al. 2017. Cell stem cell. 21(4):547-555 . PubMed
  211. Zhu K, et al. 2022. EMBO Rep. 23:e54499. PubMed
  212. Chen J, et al. 2017. Sci Rep. 10.1038/s41598-017-00654-2. PubMed
  213. Danzer H, et al. 2020. Elife. 9:00. PubMed
  214. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  215. Stefan KL, et al. 2020. Cell. 1312:183. PubMed
  216. Molgora M, et al. 2020. Cell. 182:886. PubMed
  217. Werner A, et al. 2021. iScience. 24:103076. PubMed
  218. Montes de Oca M, et al. 2016. PLoS Pathog. 12: 1005398. PubMed
  219. Starr T, et al. 2018. PLoS One. 13:e0193601. PubMed
  220. Ding L et al. 2018. Cell reports. 25(11):2972-2980 . PubMed
  221. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  222. Meng Michelle Xu et al. 2017. Immunity. 47(2):363-373 . PubMed
  223. Jaitin DA et al. 2016. Cell. 167(7):1883-1896 . PubMed
  224. Zhang J, et al. 2018. Oncoimmunology. 7:e1461301. PubMed
  225. Hackstein CP, et al. 2022. Nat Commun. 13:7472. PubMed
  226. Maller O, et al. 2020. Nat Mater. 20:548. PubMed
  227. Maulhardt HA, et al. 2020. Invest New Drugs. 1618:38. PubMed
  228. McDonald MM, et al. 2021. Cell. 184(5):1330-1347.e13. PubMed
  229. Peng V, et al. 2022. Nat Immunol. 23:619. PubMed
  230. Piirainen S, et al. 2021. Glia. 69:2459. PubMed
  231. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  232. Sakamoto K, et al. 2022. STAR Protoc. 3:101052. PubMed
  233. Tummala G, et al. 2021. Invest Ophthalmol Vis Sci. 62:41. PubMed
  234. Baptista M, et al. 2016. Nat Commun. 7:12175. PubMed
  235. Guey B, et al. 2014. Proc Natl Acad Sci U S A. 111:17254. PubMed
  236. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  237. Lee C, et al. 2020. Front Immunol. 11:77. PubMed
  238. Bohlen CJ et al. 2017. Neuron. 94(4):759-773 . PubMed
  239. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  240. Ishihara J, et al. 2018. Nat Commun. 9:2163. PubMed
  241. Liddelow S, et al. 2017. Nature. 541:481-487. PubMed
  242. Xu Z, et al. 2020. Cell Rep. 32:108041. PubMed
  243. Ang QY, et al. 2020. Cell. 181(6):1263-1275.e16. PubMed
  244. Zheng C, et al. 2021. J Extracell Vesicles. 10:e12109. PubMed
  245. Tripathi A, et al. 2021. Mol Psychiatry. 26:3043. PubMed
  246. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  247. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  248. Zhang M, et al. 2022. iScience. 25:104490. PubMed
  249. Kastenschmidt JM, et al. 2021. Cell Rep. 35:108997. PubMed
  250. Lee J, et al. 2015. Nat Commun. 6: 8499. PubMed
  251. Sen D, et al. 2016. PLoS One. 11:e0165064. PubMed
  252. Peltzer N, et al. 2018. Nature. 557:112. PubMed
  253. Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed
  254. Yang F, et al. 2021. Nat Commun. 12:3424. PubMed
  255. Kapralov AA, et al. 2020. Nat Chem Biol. 278:16. PubMed
  256. Zheng H, et al. 2021. Frontiers in Immunology. 12:645100. PubMed
  257. Chithanathan K, et al. 2022. Biology (Basel). 11:. PubMed
  258. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
  259. Erens C, et al. 2022. Biomedicines. 10:. PubMed
  260. Han J, et al. 2015. Cancer Res . 75: 5273 - 5282. PubMed
  261. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  262. Strattan E, et al. 2020. Frontiers in Immunology. 2.131944444. PubMed
  263. Ribechini E, et al. 2017. Blood Adv. 0.699305556. PubMed
  264. Tan DQ, et al. 2019. Cell Rep. 26:2316. PubMed
  265. Tong Y, et al. 2018. EBioMedicine. 39:132. PubMed
  266. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
RRID
AB_893233 (BioLegend Cat. No. 101227)
AB_893232 (BioLegend Cat. No. 101228)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

How stable is PerCP/Cyanine5.5 tandem as compared to PerCP alone?

PerCP/Cyanine5.5 is quite photostable and also better than PerCP alone in withstanding fixation.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC,SB
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 780 anti-mouse/human CD11b M1/70 FC
Spark Blue™ 574 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
KIRAVIA Blue 520™ anti-mouse/human CD11b M1/70 FC
PE/Fire™ 744 anti-mouse/human CD11b M1/70 FC
Spark PLUS UV395™ anti-mouse/human CD11b M1/70 FC
Spark Red™ 718 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
Spark PLUS B550™ anti-mouse/human CD11b M1/70 FC
Go To Top Version: 2    Revision Date: 11/19/2018

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account